25.97 USD
▲+0.06+2.89%
盘后 25.41 +0.67%
2026-08-03
市值
$4.85B
市盈率
—
EPS
-3.35
股息率
—
52 周区间
9.89 – 26.26
成交量
2.77M
Beta
1.07
目标价
39.40
52W 低 9.8952W 高 26.26
价格走势
公司简介
Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incor...